youtube_live
Q2 2027 earnings • released • EPS beat +1.32% • Revenue beat +6.39%
See resultschevron_right
AUROPHARMA:NSE
Aurobindo Pharma Ltd
₹1,800.00
arrow_upward
+0.84%(+15.00) 1D
Nov 6, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AUROPHARMA...
Open
₹1,784.30
High
₹1,805.00
Low
₹1,776.00
Mkt. cap
1.04T
Avg. vol.
971.68K
Volume
1.30M
P/E ratio
28.12
52-wk high
₹1,805.00
52-wk low
₹1,106.00
EPS
₹64.00
Shares outstanding
585.90M
No. of employees
29K
Open
₹1,784.30
High
₹1,805.00
Low
₹1,776.00
Mkt. cap
1.04T
Avg. vol.
971.68K
Volume
1.30M
P/E ratio
28.12
52-wk high
₹1,805.00
52-wk low
₹1,106.00
EPS
₹64.00
Shares outstanding
585.90M
No. of employees
29K
News stories
From web sources and news partners
TradingView
·
2 days ago
Aurobindo Pharma Q2: Net profit rises 32.5% to Rs 1,124 crore, revenue hits record high
Profile
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca. Wikipedia
About Aurobindo Pharma Ltd
CEO-
Employees29.2K
Founded1986
HeadquartersHyderabad, Andhra Pradesh, India
SectorHealth Care
IndustryPharmaceutical industry
Websiteaurobindo.com